NDC 43353-083
Diphenoxylate Hydrochloride and Atropine Sulfate 2.5 mg / 0.025 mg tablet
On the label: Aphena Pharma Solutions - Tennessee, Inc.. It's repackaged: Aphena Pharma Solutions - Tennessee, Inc. rebottles it from Mylan Pharmaceuticals Inc.'s NDC 59762-1061.
Where the pills inside were made
This label doesn't name the factory that makes the drug (it lists 1 site that tests it). Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Mylan Pharmaceuticals Inc. names for other drugs.
Repackaging site
- Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN, United States · repackages it
Recalls
- Oct 20, 2017 · Class I · Pfizer Inc.
SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
Lots: Lots: a) R83962, R93347, R93348, R93349, R93350, R93351, R93352, Exp. 2021 OCT 31; S57831, S57832, S57834, Exp. 2021 NOV 30 b) R93356, R93357, R93358, R97310, Exp. 2021 OCT 31.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Atropine and Diphenoxylate: every company that makes it
- Form
- tablet, oral
- Strength
- 2.5 mg / 0.025 mg
- Approval
- NDA AUTHORIZED GENERIC NDA012462
- On the market since
- Feb 27, 2013
- Package NDCs
43353-083-3043353-083-5343353-083-6043353-083-7043353-083-8043353-083-90- Official label
- DailyMed (National Library of Medicine), updated Jun 10, 2016
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?